Chhattisgarh Special Subsidy for Anchor Units: 5% Extra on Pharma FCI — Frequently Asked Questions

Eligible units get an additional 5% subsidy on their fixed capital investment (FCI). The overall benefit under this subsidy can go up to 110% of the project's total FCI. It is a cash subsidy from the Government of Chhattisgarh, so the rupee value depends entirely on how large the unit's fixed capital investment is.

Only the pharmaceutical sector. The subsidy is designed for large-scale pharma manufacturing and research units setting up in Chhattisgarh, and it is limited to the first five anchor industries in that sector. Projects from other industries are not covered by this particular incentive.

A project must involve an investment of more than ₹200 Crores. This threshold is verified by the Department of Industries, Government of Chhattisgarh before the proposal moves forward for review.

There is no fixed closing date. The scheme is part of the Chhattisgarh Industrial Development Policy 2024-30 and applications are treated as rolling. In practice, the real limit is numerical rather than calendar-based: the benefit is reserved for the first five qualifying pharma anchor industries, so it stays open until those slots are taken.

No. This is a cash subsidy, not an investment, so it is non-dilutive — the state does not receive shares, board seats or a stake in your business in return. Promoters retain full ownership of the unit.

Only five. The scheme is built around the anchor-industry concept, where the earliest large entrants in a priority sector are supported so they can catalyse further investment. Priority is given to the initial qualifying proposals that satisfy every stipulated condition.

The investment size involved means applicants are typically established corporate entities such as private limited companies and limited liability partnerships. The project must be a pharmaceutical manufacturing or pharma research unit being set up in Chhattisgarh with more than ₹200 Crores of investment.

The core document is a detailed project report (DPR) covering the investment plan, a breakdown of fixed capital investment and the projected economic impact of the unit. When the subsidy is claimed after approval and commissioning, supporting financial and operational documents are filed as prescribed in the policy guidelines.

Applications are processed within the framework of the Chhattisgarh Industrial Development Policy 2024-30. The promoter registers the investment project with the Department of Industries, Government of Chhattisgarh, submits the DPR and eligibility details, and the proposal is placed before the state industrial promotion board or a designated committee. The state portal at https://swsportal.cgstate.gov.in/login/ is the entry point for the process.

Approval comes first; disbursement follows successful commissioning of the unit. Once the unit is commissioned, the promoter files the subsidy claim alongside the supporting financial and operational documents specified under the policy.

No. DPIIT (Startup India) recognition is not listed as a mandatory requirement for Chhattisgarh Special Subsidy for Anchor Units: 5% Extra on Pharma FCI, though having it can strengthen your application and unlock other benefits.

Chhattisgarh Special Subsidy for Anchor Units: 5% Extra on Pharma FCI is open to startups at any stage. It is open to startups registered anywhere in India.

Chhattisgarh Special Subsidy for Anchor Units: 5% Extra on Pharma FCI is offered by Department of Industries, Government of Chhattisgarh, a government body. It is provided as non-dilutive funding.

Apply directly through the official application link on this page. Review the eligibility criteria and prepare your startup documents before you begin.